Tumor size and survival in multicentric and multifocal breast cancer

Breast

Volumn 20, Issue 3, 2011, Pages 259-263

  Rezo, Angela ^a,b,c   Dahlstrom, Jane ^a,b,c   Shadbolt, Bruce ^a,b,c   Rodins, Karl ^d   Zhang, Yanping ^b   Davis, Alison J ^a,b,c  

^a CANBERRA HOSPITAL   (Australia)

^b South East New South Wales Breast Cancer Treatment Group   (Australia)

^c AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^d Gribbles Pathology   (Australia)

Author keywords

Breast cancer; Multicentric; Multifocal; Survival; Tumor size

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTIPLE CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; TUMOR VOLUME;

EID: 79957753519     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.01.005     Document Type: Article

References (25)

1. Jain S., Rezo A., Shadbolt B., Dahlstrom JE. Synchronous multiple ipsilateral breast cancers: implications for patient management. Pathology 2009, 41:57-67.
2. Tavassoli F.A. Pathology of the breast 1999, Appleton and Lange, Hong Kong. ed 2.
3. Noguchi S., Aihara T., Koyama H., Motomura K., Inaji H., Imaoka S. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994, 74(3):872-877.
4. Teixeira M.R., Pandis N., Bardi G., Andersen J., Bohler P., Quist H., et al. Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 1997, 18(3):170-174.
5. Tsuda H., Hirohashi S. Identification of multiple breast cancers of multicentric origin by histological observations and distribution of allele loss on chromosome 16q. Cancer Res 1995, 55(15):2295-2298.
6. Wa C.V., De Vries S., Chen Y.Y., Waldman F.M., Hwang E.S. Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors. Mod Pathol 2005, 18(4):591-597.
7. Dawson P.J., Baekey P.A., Clark R.A. Mechanisms of multifocal breast cancer: an immunocytochemical study. Hum Pathol 1995, 26(9):965-969.
8. Edge S.B., Byrd D.R., Compton C.C., Fritz A.G., Greene F.L., Trotti A. AJCC cancer staging Manual 2010, Springer, Chicago. ed 7.
9. Chua B., Ung O., Taylor R., Boyages J. Frequency and predictors of axillary lymph node metastases in invasive breast cancer. ANZ J Surg 2001, 71:723-728.
10. Fowble B., Yeh I.T., Schultz D.J., Solin L.J., Rosata E.F., Jardines L., et al. The role of mastectomy in patients with stage I-II breast cancer presenting with gross multifocal or multicentric disease or diffuse microcalcifications. Int J Radiat Oncol Biol Phys 1993, 27:567-573.
11. Fish E.B., Chapman J.A., Link M.A. Assessment of tumor size for multifocal primary breast cancer. Ann Surg Oncol 1998, 5:442-446.
12. Andea A.A., Wallis T., Newman L.A., Bouwman D., Dey J., Visscher D.W. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002, 94:1383-1390.
13. Coombs N.J., Boyages J. Multifocal and multicentric breast cancer: does each focus matter?. J Clin Oncol 2005, 23:7497-7502.
14. Leopold K.A., Recht A., Schnitt S.J., Connolly J.L., Rose M.A., Silver B., et al. Results of conservative surgery and radiation therapy for multiple synchronous cancers of one breast. Int J Radiat Oncol Biol Phys 1989, 16:11-16.
15. Katz A., Strom E.A., Buchholz T.A., Theriault R., Singletary S.E., McNeese M.D. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys 2001, 50:735-742.
16. Kurtz J.M., Jacquemier J., Amalric R., Brandone H., Ayme Y., Hans D., et al. Breast-conserving therapy for macroscopically multiple cancers. Ann Surg 1990, 212:38-44.
17. Rakowsky E., Klein B., Kahan E., Derazne E., Lurie H. Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy. Breast Cancer Res Treat 1992, 21:121-131.
18. Clayton F., Hopkins C.L. Pathologic correlates of prognosis in lymph node-positive breast carcinomas. Cancer 1993, 71:1780-1790.
19. Egan R.L. Multicentric breast carcinomas: clinical-radiographic-pathologic whole organ studies and 10-year survival. Cancer 1982, 49:1123-1130.
20. Andea A.A., Bouwman D., Wallis T., Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004, 100:20-27.
21. Goldhirsch A. Meeting highlights: international expert consensus on the primary treatment of early breast cancer. Ann Oncol 2005, 6.
22. Joergensen L.E., Gunnarsdottir K.A., Lanng C., Moeller S., Rasmussen B.B. Multifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996-2001. Breast 2008.
23. Rezo A., Rodins K., Davis A., Shadbolt B., Zhang Y., Huynh F., et al. Assessment of tumour size and its relationship to nodal involvement in multifocal and multicentric breast cancer. Presented at the American Society Of Clinical Oncologists (ASCO) Annual Meeting, Chicago. J Clin Oncol 2007, 25. [abstr 10602].
24. O'Daly B.J., Sweeney K.J., Ridgway P.F., Quinn C., McDermott E.W., O'Higgins N.J., et al. The accuracy of combined versus largest diameter in staging multifocal breast cancer. J Am Coll Surg 2007, 204:282-285.
25. Tresserra F., Rodriguez I., Garcia-Yuste M., Grases P.J., Ara C., Fabregas R. Tumor size and lymph node status in multifocal breast cancer. Breast J 2007, 13:68-71.